Shiv Texchem Peer Comparison

BSE: 544272

₹106.00

₹0.80 (0.76%)

As on 22-Oct-2026 16:01IST

Market cap

₹238 Cr

Revenue (TTM)

₹2,776 Cr

P/E Ratio

3.1

P/B Ratio

0.6

Div. Yield

0 %

Edit

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Market cap (₹ Cr)	238	94	67	40	26,253
Revenue (₹ Cr)	2,776	18	1	35	5,595
Net Profit (₹ Cr)	77.82	-1.19	1.49	5.90	859.32
Net Margin (%)	2.80	-5.82	67.60	15.67	14.81
RoE (%)	20.93	--	3.36	14.76	17.37
Price to Earnings	3.06	--	45.04	6.79	30.71
Price-To-Book	0.58	13.81	1.48	0.96	5.11

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Operating Revenue	2,776.07	--	--	35.72	4,660.70
Total Income	2,782.09	--	--	38.63	4,831.99
Total Expenditure	2,640.01	--	--	29.88	3,698.56
EBITDA	136.05	--	--	5.84	962.14
Depreciation	0.25	--	--	0.43	68.16
EBIT	135.80	--	--	5.41	893.98
Interest	34.98	--	--	0.45	64.37
Other Income	6.02	--	--	2.90	171.30
Exceptional Items	--	--	--	--	--
Profit before Tax	106.84	--	--	7.86	1,000.91
Provision for Tax	29.02	--	--	2.07	245.83
Profit after Tax	77.82	--	--	5.79	755.07

Liabilities (₹ Cr)

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Shareholder's Funds	410.66	--	--	40.88	4,706.68
Minority Interest	--	--	--	--	55.40
Non-Current Liabilities	251.59	--	--	0.41	308.73
Current Liabilities	820.38	--	--	6.60	1,452.28
Total Liabilities	1,482.71	--	--	47.88	6,523.10

Assets (₹ Cr)

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Non-Current Assets	6.70	--	--	2.54	3,483.44
Current Assets	1,475.94	--	--	45.34	3,039.66
Total Assets	1,482.71	--	--	47.88	6,523.10
Total Debt*	700.53	--	--	1.81	766.57
Net Current Assets	655.56	--	--	38.74	1,587.38
Contingent Liabilities	--	--	--	1.09	34.20

Cashflow (₹ Cr)

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Cash From Operating Activities	-327.16	--	--	-1.58	382.01
Cash Flow from Investing Activities	0.08	--	--	2.01	-963.81
Cash from Financing Activities	256.30	--	--	-3.44	590.26
Net Cash Inflow / Outflow	-70.77	--	--	-3.01	8.45

Ratios

Profitability Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
ROCE (%)	15.31	--	--	20.17	22.42
ROE (%)	20.93	--	--	15.15	18.10
ROA (%)	5.69	--	--	12.73	12.99
EBIT Margin (%)	5.12	--	--	24.48	24.32
Net Margin (%)	2.80	--	--	14.99	15.63
Cash Profit Margin (%)	2.81	--	--	17.41	17.66

Growth Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Revenue Growth (%)	26.09	--	--	5.10	1.04
EBIT Growth (%)	59.10	--	--	35.31	25.11
Net Profit Growth (%)	61.74	--	--	36.33	36.02
EPS Growth (%)	61.74	--	--	36.33	32.34
Book Value Growth (%)	23.38	--	--	14.95	29.40

Valuation Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Price / Earnings	3.34	--	--	5.80	29.64
Price / Book Value	0.63	--	--	0.82	4.73
Dividend Yield (%)	0.00	--	--	1.89	0.18
EV/EBITDA	5.53	--	--	3.76	19.68
Market Cap (₹ Cr)	259.84	--	--	33.58	22,270.68

Solvency Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Debt to Equity	1.71	--	--	0.04	0.16
Short term debt to equity ratio	1.09	--	--	0.03	0.16
Current Ratio	1.80	--	--	6.87	2.09
Quick Ratio	1.00	--	--	6.64	1.57
Interest Coverage	4.05	--	--	18.46	16.55

Operating Efficiency Ratios

	Shiv Texchem	Parmax Pharma	IEL	Vasundhara Rasayan	Himadri Speciality
Debtors to sales (%)	20.22	--	--	20.87	14.94
Asset Turnover	2.03	--	--	0.79	0.80
Receivable days	66.12	--	--	59.31	52.05
Inventory Days	75.52	--	--	17.38	52.79
Payable days	54.23	--	--	59.34	38.65
Cash Conversion Cycle	87.41	--	--	17.35	66.19

Annual
Quarterly